AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Ocrelizumab in Kenya
1 product registered with PPB — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Ocrevus Concentrate For Solution For Infusion | H2022/CTD9819/21586 | F. Hoffmann- La Roche Ltd | active | 11 Apr 2028 |
Ocrelizumab — PPB Registration Details
PPB (Kenya) has 1 registered product containing Ocrelizumab, of which 1 is currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Ocrelizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.